Objective: The aim of this study is dosimetric comparison of 3-D conformal radiotherapy (3D-CRT), intensity modulated radiotherapy (IMRT) and hybrid IMRT (h-IMRT) planning techniques above the recommended standard treatment doses for esophageal cancer patients in terms of target volume dose distribution and critical organ protection. The routine applicability of the h-IMRT technique have also been evaluated. Material and Methods: Totally 42 treatment plans for 59.4 Gy dose were designed for 14 esophageal cancer patients with 3D-CRT, IMRT and h-IMRT techniques. Dosimetric evaluation and comparison of the techniques were performed according to the parameters of dose volume histogram (DVH), homogeneity index (HI), conformity index (CI) and monitor unit (MU) calculations. The quality control of the dose distributions was calculated by treatment planning system (TPS) and, 2-dimensional dose distributions and point absolute doses were measured with MatriXX and ion chambers respectively. Results: In all regions of the esophagus, IMRT technique was found to be more successful than the 3D-CRT and h-IMRT techniques in terms of PTV coverage. HI was in accepted limits for all techniques but, IMRT and h-IMRT techniques were better for CI. As expected, treatment duration and MU parameters were found to be high in IMRT technique. Conclusion: Although all plans were within acceptable limits, dosimetric comparison of different planning techniques, revealed that 3D-CRT had statistically significant differences from IMRT planning technique in terms of planned target volume (PTV) coverage, OAR protection, HI, CI, MU and treatment duration above the standart doses. From the aspect of treatment duration and MU parameters, h-IMRT technique can be considered as an alternative planning option.
Keywords: IMRT; esophageal cancer; radiotherapy
Amaç: Bu çalışmanın amacı özofagus kanserli hastalarda, hedef hacim doz dağılımı ve kritik organ korunması açısından, üç boyutlu konformal radyoterapi (3-DCRT), yoğunluk ayarlı radyoterapi (IMRT) ve hibrit IMRT (hIMRT) planlama tekniklerinin dozimetrik olarak karşılaştırılmasıdır. H-IMRT tekniğinin rutin kullanımı da ayrıca değerlendirilmiştir. Gereç ve Yöntemler: Özofagus kanserli 14 hastaya, 3D-CRT, IMRT ve h-IMRT tekniklerinin her biri ile 59,4 Gy total doz için toplam 42 plan yapılmıştır. Dozimetrik değerlendirmeler ve tekniklerin karşılaştırılması, doz hacim histogramları (DVH), homojenite index (HI), konformite indexi (CI) ve monitör ünite (MU) hesaplama parametrelerine göre yapılmıştır. Doz dağılımlarının kalite kontrolleri tedavi planlama sistemi (TPS) yardımıyla yapılmıştır, iki boyutlu doz dağılımları ve nokta dozlar sırasıyla MatriXX ve iyon çemberleriyle ölçülmüştür. Bulgular: Özofagusun tüm bölgelerinde IMRT tekniği PTV kapsaması açısından 3D-CRT ve h-IMRT tekniklerinden daha başarılı bulunmuştur. HI, tüm tekniklerde kabul edilebilir limitlerdedir, ancak CI açısından IMRT ve h-IMRT teknikleri daha iyi bulunmuştur. Beklenildiği üzere, tedavi süresi ve MU, IMRT tekniğinde yüksek bulunmuştur. Sonuç: Tüm tekniklerle yapılan planlamalar kabul edilebilir sınırlarda olsa da, farklı planlama tekniklerinin dozimetrik karşılaştırmaları, standart tedavi dozlarının üstündeki dozlarda 3D-CRT planlama tekniğinin PTV sarımı, riskli organ korunması (OAR), HI, CI, MU ve tedavi süresi bakımından belirgin istatistiksel farklılıkları olduğunu ortaya koymuştur. Tedavi süresi ve MU parametreleri açısından, h-IMRT tekniği alternatif planlama tekniği olarak değerlendirilebilir
Anahtar Kelimeler: IMRT; özofagus kanseri; radyoterapi
- Choi KH, Kim J, Lee SW, Kang YN,Jang H. Dosimetric comparison between modulated arc therapy and static intensity modulatedradiotherapy in thoracic esophageal cancer: a single institutional experience. Radiat OncolJ. 2018;36(1):63-70.[Crossref] [PubMed] [PMC]
- National Cancer Institute. Surveillance, Epidemiology, and End ResultProgram. Cancer stat facts: esophageal cancer.[Link]
- Vosmik M, Petera J, Sirak I, HodekM, Paluska P, Dolezal J, et al. Technological advances in radiotherapy for esophagealcancer. World J Gastroenterol. 201028;16(44):5555-64.[Crossref] [PubMed] [PMC]
- Fountoulakis A, Souglakos J, ViniL, Douridas GN, Koumarianou A, Kountourakis P, et al. Consensus statement of the Hellenicand Cypriot Oesophageal Cancer Study Group on the diagnosis, staging and management ofoesophageal cancer. Updates Surg. 2019;71(4):599-624.[Crossref] [PubMed]
- Hou J, Zou K, Yang C, Leng X, XuY. Clinicopathological and prognostic significance of circulating tumor cells in patientswith esophageal cancer: a meta-analysis. Onco Targets Ther. 2018;2;11:8053-61.[Crossref] [PubMed] [PMC]
- Allaveisi F, Moghadam AN.Comparison between the four-field box and field-in-field techniques for conformalradiotherapy of the esophagus using dose-volume histograms and normal tissue complicationprobabilities. Jpn J Radiol. 2017;35(6):327-34.[Crossref] [PubMed]
- Abbas AS, Moseley D, Kassam Z, KimSM, Cho C. Volumetric-modulated arc therapy for the treatment of a large planning targetvolume in thoracic esophageal cancer. J Appl Clin Med Phys. 2013;6;14(3):4269.[Crossref] [PubMed] [PMC]
- Hazard L, Yang G, McAleer MF,Hayman J, Willett C. Principles and techniques of radiation therapy for esophageal andgastroesophageal junction cancers. J Natl Compr Canc Netw. 2008;6(9):870-8.[Crossref] [PubMed]
- Minsky BD, Pajak TF, Ginsberg RJ,Pisansky TM, Martenson J, Komaki R, et al. INT 0123 (radiation therapy oncology group 94-05)phase III trial of combined-modality therapy for esophageal cancer: high-dose versusstandard-dose radiation therapy. J Clin Oncol. 2002;1;20(5):1167-74.[Crossref] [PubMed]
- Zhang W, Luo Y, Wang X, Han G,Wang P, Yuan W, et al. Dose-escalated radiotherapy improved survival for esophageal cancerpatients with a clinical complete response after standard-dose radiotherapy with concurrentchemotherapy. Cancer Manag Res. 2018;14;10:2675-82.[Crossref] [PubMed] [PMC]
- Deng Y, Bian C, Tao H, Zhang H.Improved survival with higher radiation dose for esophageal squamous cell carcinoma patientstreated with definitive chemoradiotherapy. Oncotarget. 2017;6;8(45):79662-9.[Crossref] [PubMed] [PMC]
- Luo HS, Huang HC, Lin LX. Effectof modern high-dose versus standard-dose radiation in definitive concurrentchemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis. RadiatOncol. 2019;17;14(1):178.[Crossref] [PubMed] [PMC]
- Mayo CS, Urie MM, Fitzgerald TJ,Ding L, Lo YC, Bogdanov M, et al. Hybrid IMRT for treatment of cancers of the lung andesophagus. Int J Radiat Oncol Biol Phys. 2008;1;71(5):1408-18.[Crossref] [PubMed]
- Journal of the ICRU. Report 83prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy(IMRT). Oxford University Press; 2010;10(1).[Crossref]
- Shaw E, Kline R, Gillin M,Souhami L, Hirschfeld A, Dinapoli R, et al. Radiation therapy oncology group: radiosurgeryquality assurance guidelines. Int J Radiat Oncol Biol Phys. 1993;1;27(5):1231-9.[Crossref] [PubMed]
- ICRU. Prescribing, recording and reporting photon beam therapy(supplement to ICRU report 50). Bethesda, MD; 1999.[Link]
- Fenkell L, Kaminsky I, Breen S,Huang S, Van Prooijen M, Ringash J, et al. Dosimetric comparison of IMRT vs. 3D conformalradiotherapy in the treatment of cancer of the cervical esophagus. Radiother Oncol.2008;89(3):287-91.[Crossref] [PubMed]
- Fu Y, Deng M, Zhou X, Lin Q, DuB, Tian X, et al. Dosimetric effect of beam arrangement for intensity-modulated radiationtherapy in the treatment of upper thoracic esophageal carcinoma. Med Dosim.2017;42(1):47-52.[Crossref] [PubMed]
- Petrova D, Smickovska S,Lazarevska E. Conformity Index and Homogeneity Index of the Postoperative Whole BreastRadiotherapy. Open Access Maced J Med Sci. 2017;17;5(6):736-9.[Crossref] [PubMed] [PMC]
- Rodrigues G, Lock M, D'Souza D,Yu E, Van Dyk J. Prediction of radiation pneumonitis by dose - volume histogram parametersin lung cancer--a systematic review. Radiother Oncol. 2004;71(2):127-38.[Crossref] [PubMed]
- Kharofa J, Cohen EP, Tomic R,Xiang Q, Gore E. Decreased risk of radiation pneumonitis with incidental concurrent use ofangiotensin-converting enzyme inhibitors and thoracic radiation therapy. Int J Radiat OncolBiol Phys. 2012;1;84(1):238-43.[Crossref] [PubMed]
- Wu Z, Xie C, Hu M, Han C, Yi J,Zhou Y, et al. Dosimetric benefits of IMRT and VMAT in the treatment of middle thoracicesophageal cancer: is the conformal radiotherapy still an alternative option? J Appl ClinMed Phys. 2014;8;15(3):93-101.[Crossref] [PubMed] [PMC]
- Lin JC, Tsai JT, Chang CC, JenYM, Li MH, Liu WH, et al.. Comparing treatment plan in all locations of esophageal cancer:volumetric modulated arc therapy versus intensity-modulated radiotherapy. Medicine(Baltimore). 2015;94(17):e750.[Crossref] [PubMed] [PMC]
- Aoyama H, Westerly DC, Mackie TR,Olivera GH, Bentzen SM, Patel RR, et al. Integral radiation dose to normal structures withconformal external beam radiation. Int J Radiat Oncol Biol Phys. 2006;1;64(3):962-7.[Crossref] [PubMed]
- Hermanto U, Frija EK, Lii MJ,Chang EL, Mahajan A, Woo SY, et al. Intensity-modulated radiotherapy (IMRT) and conventionalthree-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase theintegral dose to normal brain? Int J Radiat Oncol Biol Phys. 2007;15;67(4):1135-44.[Crossref] [PubMed]
- Khan FM. Treatment Planning: Isodose distributions. In: The Physics ofRadiation Therapy. 5th ed. Faiz MK, Gibbons JP, eds. Philadelphia-USA: Lippincott Williams& Wilkins Company; 2014. p.182-206.
.: Process List